2m 2m 2m 2m 2m 2m 2m
ATEA PHARMA (AVIR)
NASDAQ
$4.21$0.00 (0.00%)
Price as of Jun 03, 2026 4:10 PM EDT- $373.7MMarket Cap
- 32.61%1-Year Change
- BiotechnologyIndustry
ATEA PHARMA (AVIR)
$4.21$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | 351.4M 0.00% | |
Cost of Revenue | 110,000 0.00% | 110,000 0.00% | 110,000 N/A | N/A N/A | |
Gross Profit | -110,000 0.00% | -110,000 0.00% | -110,000 -100.03% | 351.4M 0.00% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -148.0M +2.72% | -144.1M +26.14% | -114.2M +39.43% | -81.9M -51.00% | |
Depreciation and Amortization Expense | 416,000 0.00% | 416,000 0.00% | 416,000 +60.00% | 260,000 +796.55% | |
Total Operating Expenses | 180.9M -6.25% | 192.9M +17.54% | 164.2M +25.65% | 130.7M -38.66% | |
Operating Profit | -180.9M -6.25% | -192.9M +17.54% | -164.2M +25.65% | -130.7M -194.42% | |
Interest Income | 16.4M -35.76% | 25.5M -12.78% | 29.2M +162.08% | 11.2M +5,135.21% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 16.4M -35.76% | 25.5M -12.78% | 29.2M +162.08% | 11.2M +5,135.21% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Income before Taxes | -164.5M -1.76% | -167.5M +24.10% | -134.9M +12.92% | -119.5M -186.22% | |
Income Taxes | -6.2M -766.16% | 925,000 -9.14% | 1.0M +128.36% | -3.6M -120.63% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -158.3M -5.96% | -168.4M +23.85% | -136.0M +17.30% | -115.9M -195.64% | |
Net Income from Continuing Operations Applicable to Common | -164.5M -1.76% | -167.5M +24.10% | -134.9M +12.92% | -119.5M -186.22% | |
Basic EPS and Net Income | -1.94 -3.00% | -2.00 +22.70% | -1.63 +17.27% | -1.39 -195.21% | |
Diluted EPS and Net Income | -1.94 -3.00% | -2.00 +22.70% | -1.63 +17.27% | -1.39 -201.46% | |
Basic Weighted Average Shares | 81.5M -3.29% | 84.3M +1.05% | 83.4M +0.17% | 83.2M +0.51% | |
Diluted Weighted Average Shares | 81.5M -3.29% | 84.3M +1.05% | 83.4M +0.17% | 83.2M -5.67% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 95.7M +47.94% | 64.7M -55.02% | 143.8M -23.69% | 188.5M -75.34% | |
Short-Term Investments | 206.1M -47.15% | 390.0M -10.19% | 434.3M -5.23% | 458.2M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 301.8M -33.62% | 454.7M -21.34% | 578.1M -10.61% | 646.7M -15.39% | |
Total Current Assets | 311.0M -32.74% | 462.4M -21.70% | 590.5M -10.66% | 660.9M -14.43% | |
Accumulated Depreciation | 1.5M +37.65% | 1.1M +60.38% | 689,000 +152.38% | 273,000 +69.57% | |
Property and Plant and Equipment and Net | 457,000 -47.65% | 873,000 -32.27% | 1.3M -24.40% | 1.7M +7,313.04% | |
Total Long-Term Assets | 3.1M +1,491.88% | 197,000 -85.89% | 1.4M -6.56% | 1.5M +220.60% | |
Total Assets | 315.2M -32.16% | 464.7M -21.90% | 595.0M -10.76% | 666.7M -13.74% | |
Income Taxes Payable | 0 -100.00% | 6.4M +10.39% | 5.8M +9.57% | 5.3M +104.32% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 39.8M +113.86% | 18.6M -42.54% | 32.4M +75.21% | 18.5M -67.52% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 0 -100.00% | 842,000 -48.72% | 1.6M -31.67% | 2.4M -59.49% | |
Total Liabilities | 39.8M +54.20% | 25.8M -35.13% | 39.8M +52.19% | 26.1M -58.39% | |
Retained Earnings | -522.6M +43.48% | -364.2M +85.98% | -195.8M +227.05% | -59.9M -206.87% | |
Total Stockholders Equity | 275.4M -37.24% | 438.9M -20.95% | 555.2M -13.33% | 640.6M -9.79% | |
Total Shares Outstanding | 78.1M -7.50% | 84.5M +1.23% | 83.4M +0.18% | 83.3M +0.22% | |
Cash Flow | |||||
Cash from Operating Activities | -132.0M -2.56% | -135.5M +58.67% | -85.4M -29.42% | -121.0M +39.05% | |
Capital Expenditures | N/A N/A | N/A N/A | 1.9M 0.00% | 1.9M +48,475.00% | |
Cash from Investing Activities | 188.8M +236.50% | 56.1M +39.21% | 40.3M +108.85% | -455.4M +11,385,150.00% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -25.7M -9,742.32% | 267,000 +3.89% | 257,000 -30.54% | 370,000 -74.74% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | -37.18% -194.42% | |
Return on Assets | -40.61% +27.77% | -31.78% +47.47% | -21.55% +33.84% | -16.10% -208.72% | |
Return on Equity | -44.34% +30.87% | -33.88% +48.98% | -22.74% +32.49% | -17.16% -189.07% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | 0.00% -100.00% | |
Current Ratio | 7.82 -68.55% | 24.85 +36.28% | 18.24 -49.01% | 35.77 +163.41% | |
Cash Ratio | 2.41 -30.82% | 3.48 -21.71% | 4.44 -56.44% | 10.20 -24.10% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow